Additionally, Claritin tablets and Claritin Reditab tablets have been approved for these uses in patients over the age of seven. In Japan, Schering-Plough co-markets the Claritin line of medications with Shionogi & Co.
Claritin is marketed in over 100 countries worldwide and is available in several countries without a prescription. Dry syrup is a unique granule formulation available only in Japan.
Robert Spiegel, chief medical officer and senior vice president, Schering- Plough Research Institute, said: “Claritin dry syrup is an easily administered, long-lasting formulation for treating children as young as age three, and approval of this new formulation provides an important treatment option for pediatric patients in Japan.”